Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
36°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
March 26, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
March 25, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to launch U.S. Customer Digital Media Sales Campaign
February 28, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Launching our most comprehensive test and expanding into new global markets
January 31, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
January 05, 2024
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
September 12, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
September 11, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TV
September 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Annual Results – Momentum Building on our Commercial Plans
August 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Limited Announces Updated Investor Presentation
August 09, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Quarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
July 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
July 21, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
May 23, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
New Publication Validates geneType for Melanoma Risk Assessment
April 28, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Quarterly Business Update – March 2023
April 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Publication Validates geneType Prostate Cancer Risk Test
April 19, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial Fibrillation
March 27, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Back-to-back Studies Validate geneType Breast Cancer Risk Test
March 13, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
New Publication Highlights geneType’s Ability to Detect Breast Cancer Earlier and Provide Data for Risk Stratification
February 09, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Announces $5 Million Registered Direct Offering
February 03, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer
February 03, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
GTG to form Strategic Alliance with global testing leader QIAGEN
February 01, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Quarterly Business Update – December 2022; Sixth Consecutive Quarter of Growth
January 30, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Presented Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk at ASCOGI Cancer Symposium
January 24, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Genetic Technologies Provides Business Update
January 11, 2023
From
Genetic Technologies Ltd
Via
GlobeNewswire
Tickers
ASX:GTG
GENE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.